• Home >>
  • Pharmaceuticals and Healthcare

Plasma Fractionation Market : Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis and Competitive Analysis 2017 - 2025

  • ID : 58961
  • Date : February, 2018
  • Region : Global
  • Pages :

CHOOSE LICENCE TYPE

Global Plasma Fractionation Market, by product (albumin,coagulation factor concentrates, immunoglobulin, protease inhibitor and other plasma products), application (neurology, immunology, haematology, pulmonology, critical care, heamto-ocology, rheumatology and other application) and end user (academic institutes, clinical research laboratories and hospitals& clinics) forecast till 2025.



Market Scenario
Plasma fractionation is process of parting of plasma protein which is a component of blood derived by blood fractionation. Increased prevalence of respiratory diseases such as emphysema and AATD are some of the factors boost the growth of the market. Application of plasma fractionation in preventing and treating of life threatening diseases caused by immunologic disorders, trauma and infection are creating demand and fuel to growth of the market. Rise in number of haemophilic patient are one of the opportunity for this market. Usage of plasma in the production of packaging material and therapeutic area for treating protein deficiencies are fuelling the market for further growth. However, stringent government regulations, high cost and limited reimbursement are hampers growth of the market.


Segmentation
The global plasma fractionation market is segmented on the basis of product, application and end user.
On the basis of product, the market is segmented into albumin, coagulation factor concentrates, immunoglobulin, protease inhibitor and other plasma products.
On the basis of application, the market is segmented into neurology, immunology, haematology, pulmonology, critical care, heamto-ocology, rheumatology and other application.
On the basis of end user, the market is segmented into academic institutes, clinical research laboratories and hospitals& clinics.


Regional Analysis
North America holds the largest share of the market due to increased expenditure on healthcare per capita, increased demand of patients for advanced healthcare facilities and rising use of prophylaxis treatment for diagnosed patient. Asia Pacific is expected to grow at higher rate as growing geriatric population and improving healthcare infrastructure are responsible.


Key Players
The key players in the market are: CSL, Octapharma AG, Grifols S.A, Kedrion S.p.A, Shire, Bio Product Laboratory, Sanquin, Biotest, LFB, and Japan Blood Products Organization.


Segmentation
By Product
• Albumin
• Coagulation Factor Concentrates
• Immunoglobulin
• Protease Inhibitor
• Other Plasma Products
By Application
• Neurology
• Immunology
• Haematology
• Pulmonology
• Critical care
• Heamto-Ocology
• Rheumatology
• Other Application
By End User
• Academic Institutes
• Clinical Research Laboratories
• Hospitals& Clinics
By Region
• North America
• Europe
• Asia Pacific
• LAMEA

Research Scope
 
The study for Plasma Fractionation Market will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025



The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 


Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 


The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 
 
1. Introduction
1.1. Market Definition
1.2. Market Scope
2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions
3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 
3.6. Market Overview
4. Product Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Albumin
4.2.2. coagulation factor concentrates
4.2.3. immunoglobulin
4.2.4. protease inhibitor
4.2.5. other plasma products
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
5. Application Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Neurology
5.2.2. Immunology
5.2.3. Haematology
5.2.4. Pulmonology
5.2.5. Critical care
5.2.6. Heamto-Ocology
5.2.7. Rheumatology
5.2.8. Other Application
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
6. End User Overview
6.1. Introduction
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. Academic Institutes
6.2.2. Clinical Research Laboratories
6.2.3. Hospitals& Clinics
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
7. Regional Overview
7.1. Introduction
7.2. Market Size & Forecast, 2015 to 2025
7.2.1. North America
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.1.3. Mexico 
7.2.2. Europe
7.2.2.1. UK
7.2.2.2. Germany
7.2.2.3. France
7.2.2.4. Italy 
7.2.2.5. Spain
7.2.2.6. Rest of Europe
7.2.3. Asia-Pacific
7.2.3.1. China
7.2.3.2. India
7.2.3.3. Japan
7.2.3.4. South Korea
7.2.3.5. Rest of Asia-Pacific
7.2.4. LAMEA
7.2.4.1. Brazil
7.2.4.2. UAE
7.2.4.3. South Africa
7.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)
8. Manufacturer/ Vendor Profile
8.1. The following attributes will be considered while profiling key manufacturers in this industry: 
8.1.1. Company Overview
8.1.2. Financial Synopsis
8.1.3. Recent Developments
8.1.4. R&D Investments (if any)
8.1.5. Strategy Overview (Analyst Perspective)
8.1.6. Product Portfolio
8.2. Companies Profiled
8.2.1. CSL
8.2.2. Octapharma AG
8.2.3. Grifols S.A
8.2.4. Kedrion S.p.A
8.2.5. Shire
8.2.6. Bio Product Laboratory
8.2.7. Sanquin
8.2.8. Biotest
8.2.9. LFB
8.2.10. Japan Blood Products Organization
 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology